{
    "clinical_study": {
        "@rank": "25006", 
        "acronym": "LYMPHOS", 
        "arm_group": {
            "arm_group_label": "lymphoma", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess changes of bone mineral density (BMD) at 12 months\n      during the therapeutic management of patients with lymphoma."
        }, 
        "brief_title": "Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Lymphoma.", 
            "Osteoporosis."
        ], 
        "condition_browse": {
            "mesh_term": [
                "Lymphoma", 
                "Osteoporosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects aged 18 to 80 with lymphoma,\n\n          -  Histological diagnosis of Hodgkin's lymphoma (HL) or non-Hodgkin lymphoma (NHL) of\n             follicular or aggressive (large cell or other),\n\n          -  Patients who have not yet started their chemotherapy or who have started for less\n             than a month\n\n          -  Patient has signed informed consent.\n\n        Exclusion Criteria:\n\n          -  Pathological fractures at the time of initial diagnosis of lymphoma,\n\n          -  Compression of neurological epidural,\n\n          -  Patients receiving treatment for osteoporosis (including bisphosphonates, selective\n             modulators of estrogen receptor, calcitonin and parathyroid hormone Teriparatide).\n\n          -  Discovery of osteoporosis or osteopenia fracture during the initial evaluation\n             requiring the establishment of an osteoporosis treatment,\n\n          -  Radiotherapy to the lumbar spine or hip studied,\n\n          -  Location of bone lymphoma in the lumbar spine or hip studied,\n\n          -  History of disorders affecting bone metabolism (prostate cancer with androgen,\n             stomach cancer, hyperparathyroidism, hyperthyroidism, uncontrolled ...)\n\n          -  A person incapable of giving consent personally,\n\n          -  Pregnant or breastfeeding women,\n\n          -  Protected Person (under guardianship)\n\n          -  Patient not affiliated with a social security system."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01841814", 
            "org_study_id": "PI11-Dr.DAMAJ/PACCOU"
        }, 
        "intervention": {
            "arm_group_label": "lymphoma", 
            "intervention_name": "Bone densitometry.", 
            "intervention_type": "Radiation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Lymphoma", 
            "Osteoporosis", 
            "Chemotherapy", 
            "Patient with"
        ], 
        "lastchanged_date": "April 24, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Amiens", 
                    "country": "France", 
                    "state": "Picardie", 
                    "zip": "80054"
                }, 
                "name": "Gandhi DAMAJ"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy: Prospective Longitudinal Study Over 12 Months.", 
        "overall_official": {
            "affiliation": "CHU d'Amiens France", 
            "last_name": "Gandhi DAMAJ, Doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "FRANCE: National Security Agency of Medicines and Health Products", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients will have a review of bone densitometry.", 
            "measure": "Measurement of bone mineral density (BMD).", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline of bone mineral density at 12 months."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01841814"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Universitaire, Amiens", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire, Amiens", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}